JEAN-PHILIPPE MÉRY, M.D.; SAID MOSTEFA, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Cohen and associates reported in the April issue (Ann Intern Med 82:466-473) a case of resolution of primary amyloidosis during chemotherapy. In this patient, who had a renal localization of amyloidosis, a striking improvement occurred, illustrated by the disappearance of proteinuria and nephrotic syndrome together with return of renal function to normal. The authors suggested that the recovery was due to the treatment (melphalan, penicillamine, prednisone, and fluoxymesterone). However they did not give convincing evidence for such a conclusion; we believe that one must be very cautious before admitting the value of any treatment in renal amyloidosis
MÉRY J, MOSTEFA S. Remission in Renal Amyloidosis. Ann Intern Med. ;83:581. doi: 10.7326/0003-4819-83-4-581_1
Download citation file:
Published: Ann Intern Med. 1975;83(4):581.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use